AI assistant
AtriCure, Inc. — Director's Dealing 2020
Aug 10, 2020
31802_dirs_2020-08-10_8756ff25-b4d1-4fbc-8947-f848a32a557a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2020-08-06
Reporting Person: Wirick Angela L (Chief Financial Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 47505 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Non-qualified Stock Option (right to buy) | $16.95 | 2024-07-28 | Common Stock (5000) | Direct |
Footnotes
F1: Includes 24,044 shares of unvested restricted stock awarded under the AtriCure, Inc. 2014 Equity Incentive Plan. One third of the shares vest annually upon the respective one, two and three year anniversaries of the date of grant. Restricted stock awarded prior to 2018 vests at a rate of 25% on the first anniversary date of the grant and ratably each month thereafter over the following three years.
F2: These options were granted on July 28, 2014 and vest at a rate of 25% on the first anniversary date of the grant and ratably each month thereafter over the following three years.